Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Nubeqa
Pharma
Bayer CEO Anderson sticking out firm's revitalization scheme
CEO Bill Anderson thinks Bayer has a good thing going and that it will be better served by adopting a wait-and-see approach for now.
Fraiser Kansteiner
Aug 4, 2026 10:40am
Biosimilar competiton takes big bite out of Bayer's Eylea sales
May 12, 2026 10:51am
Bayer earns FDA untitled letter for Nubeqa ad’s risk information
Apr 30, 2026 5:25am
Bayer's pharma division sees one more year of declining sales
Mar 4, 2026 11:35am
Bayer sues J&J over 'deeply flawed' Erleada promotional claims
Feb 23, 2026 1:03pm
Bayer has Tony Romo calling plays in Nubeqa drive
Jan 29, 2026 10:40am
